Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Melittin, a peptide in bee venom, disrupted cancer cell membranes in preclinical animal and laboratory models, with triple-negative breast cancer cells showing particular susceptibility.
Hematology/Oncology April 28th 2026
News Medical
Preclinical findings point to a potential role for extracellular vesicles in cartilage repair, offering insight into future directions for osteoarthritis research.
Ambulatory Care Nursing April 16th 2026